Product Standardization: Playing to Win
Recent analysis by McKinsey & Company suggests standardization savings already captured by the US health care industry amount only to some 5-10% of total product spending. Benchmarks from other industries imply that an additional 20-25% savings is possible.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.